Filing Details
- Accession Number:
- 0001562180-19-000863
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-08 19:14:30
- Reporting Period:
- 2019-02-06
- Accepted Time:
- 2019-02-08 19:14:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1100412 | Array Biopharma Inc | ARRY | Pharmaceutical Preparations (2834) | 841460811 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1191818 | Kyle Lefkoff | C/O Boulder Ventures 1941 Pearl Street, Suite 300 Boulder CO 80302 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-02-06 | 25,000 | $10.47 | 47,720 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-02-06 | 25,000 | $20.51 | 22,720 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-02-06 | 5,000 | $20.82 | 25,000 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2019-02-06 | 5,000 | $20.85 | 20,000 | No | 4 | S | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2019-02-06 | 25,000 | $0.00 | 25,000 | $10.47 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2027-10-26 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 15,000 | Indirect | See footnote |
Footnotes
- The price reported for these shares is the weighted average sale price of transactions made at prices from $20.50 to $20.58. Details of actual prices for shares sold are available from the Reporting Person upon request.
- The sale was made by the Reporting Person as custodian for his son under the Colorado Uniform Gifts to Minors Act.
- The price reported for these shares is the weighted average sale price of transactions made at prices from $20.785 to $20.834. Details of actual prices for shares sold are available from the Reporting Person upon request.
- Comprised of shares of common stock in trust for the benefit of the Reporting Person's minor children.
- The price reported for these shares is the weighted average sale price of transactions made at prices from $20.805 to $20.864. Details of actual prices for shares sold are available from the Reporting Person upon request.
- Comprised of common stock held by BV Partners III Profit Sharing account for the benefit of the Reporting Person.
- The options vested on October 26, 2018.